Related Experiment Video
Updated: Apr 10, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Generation of Spatio-Temporally Controlled Targeted Somatic Mutations in the Mouse
Daniel Metzger1, Pierre Chambon1
1Institut de Génétique et de Biologie Moléculaire et Cellulaire, Université de Strasbourg, and Collège de France, Illkirch, France.
Abstract:
The generation of ligand-activated site-specific Cre recombinases has led to the development of cell type-specific temporally controlled targeted somatic mutagenesis in the mouse. We illustrate this technique using K14-Cre-ER(T2) transgenic mice that express the tamoxifen (tam)-activatable Cre-ER(T2) recombinase in epidermal basal keratinocytes to induce mutations in epidermal keratinocytes of adult mice. Our highly reproducible technique, based on induction of Cre-ER(T2) recombinase activity by tamoxifen administration at low doses (once daily 100-µg intraperitoneal injection for 5 days), has allowed the generation of site-directed somatic mutations of numerous genes in mouse epidermal keratinocytes, and several mouse models of human diseases. The present step-by-step protocol describes how to introduce temporally controlled targeted mutations in epidermal keratinocytes of adult mice. Curr. Protoc. Mouse Biol. 1:55-70. © 2011 by John Wiley & Sons, Inc.
Insights
This study details a tamoxifen-inducible Cre-ER(T2) system for precise genetic mutations in mouse skin cells. The method enables controlled gene editing in adult mice for disease modeling.
Area of Science:
- Genetics
- Molecular Biology
- Dermatology
Background:
- Ligand-activated Cre recombinases enable targeted somatic mutagenesis.
- Cre-ER(T2) recombinase activity can be controlled by tamoxifen.
Purpose of the Study:
- To describe a protocol for temporally controlled, targeted somatic mutagenesis in mouse epidermal keratinocytes.
- To demonstrate the utility of K14-Cre-ER(T2) transgenic mice for inducing mutations in adult mice.
Main Methods:
- Utilizing K14-Cre-ER(T2) transgenic mice expressing tamoxifen-activatable Cre recombinase.
- Administering low-dose tamoxifen (100-µg daily for 5 days) to induce Cre-ER(T2) activity.
- Inducing site-specific somatic mutations in epidermal keratinocytes of adult mice.
Main Results:
- Highly reproducible generation of site-directed somatic mutations in mouse epidermal keratinocytes.
- Successful application of the technique in creating mouse models for human diseases.
- Demonstrated efficacy of low-dose tamoxifen for controlled genetic manipulation.
Conclusions:
- The described protocol provides a reliable method for temporal control of targeted somatic mutations in mouse epidermis.
- This technique facilitates the generation of genetically modified mouse models for studying human diseases.
- Ligand-inducible Cre-ER(T2) systems offer precise tools for somatic mutagenesis in specific cell types.
More Related Videos
Related Concept Videos
In-vitro Mutagenesis
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

